Acute rhabdomyolysis and delayed pericardial effusion in an Italian patient with Ebola virus disease: a case report.

Emanuele Nicastri, Antonio Brucato, Nicola Petrosillo, Gianluigi Biava, Timothy M Uyeki, Giuseppe Ippolito

Journal: BMC infectious diseases 2018;17(1):597

PMID: 28854896

Abstract

BACKGROUND

During the 2013-2016 West Africa Ebola virus disease (EVD) epidemic, some EVD patients, mostly health care workers, were evacuated to Europe and the USA.

CASE PRESENTATION

In May 2015, a 37-year old male nurse contracted Ebola virus disease in Sierra Leone. After Ebola virus detection in plasma, he was medically-evacuated to Italy. At admission, rhabdomyolysis was clinically and laboratory-diagnosed and was treated with aggressive hydration, oral favipiravir and intravenous investigational monoclonal antibodies against Ebola virus. The recovery clinical phase was complicated by a febrile thrombocytopenic syndrome with pericardial effusion treated with corticosteroids for 10 days and indomethacin for 2 months. No evidence of recurrence is reported.

CONCLUSIONS

A febrile thrombocytopenic syndrome with pericardial effusion during the recovery phase of EVD appears to be uncommon. Clinical improvement with corticosteroid treatment suggests that an immune-mediated mechanism contributed to the pericardial effusion.

Address: National Institute for Infectious Diseases - INMI - Lazzaro Spallanzani IRCCS, Via Portuense 292, 00149, Rome, Italy. [email protected].; Internal Medicine Ospedale Papa Giovanni XXIII, Bergamo, Italy.; National Institute for Infectious Diseases - INMI - Lazzaro Spallanzani IRCCS, Via Portuense 292, 00149, Rome, Italy.; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.